Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Aderbasib (100-1000μM
343(2):239-48
Docetaxel displays potent and broad antineoplastic properties
4-benzoxazepin-7-yl]pyridin-2-amine
Ketanserin depresses and in certain experiments reverses the vasoconstrictor response to 5-hydroxytryptamine in the perfused guinea-pig stomach
M3258 Size:Contact [email protected] for quotation Aderbasib (100-1000μMM3258 is an orally bioavailable, potent, reversible and highly selective immunoproteasome subunit LMP7 (5i) inhibitor. M3258 exerts high biochemical (IC50=3. 6 nM) and cellular (IC50=3. 4 nM) potency against the LMP7 subunit. M3258 shows strong antitumor efficacy in multiple myeloma xenograft models. M3258 leads to a significant and prolonged suppression of tumor LMP7 activity and ubiquitinated protein turnover and the induction of apoptosis in
US$ 3674.00
US$ 20.00
US$ 81.00
US$ 112.00
US$ 190.00
US$ 108.00
US$ 136.50
US$ 129.00
US$ 172.00
US$ 126.00